Literature DB >> 17461729

Current state of imaging protein-protein interactions in vivo with genetically encoded reporters.

Victor Villalobos1, Snehal Naik, David Piwnica-Worms.   

Abstract

Signaling pathways regulating proliferation, differentiation, and inflammation are commonly mediated through protein-protein interactions as well as reversible modification (e.g., phosphorylation) of proteins. To facilitate the study of regulated protein-protein interactions in cells and living animals, new imaging tools, many based on optical signals and capable of quantifying protein interactions in vivo, have advanced the study of induced protein interactions and their modification, as well as accelerated the rate of acquisition of these data. In particular, use of protein fragment complementation as a reporter strategy can accurately and rapidly dissect protein interactions with a variety of readouts, including absorbance, fluorescence, and bioluminescence. This review focuses on the development and validation of bioluminescent protein fragment complementation reporters that use either Renilla luciferase or firefly luciferase in vivo. Enhanced luciferase complementation provides a platform for near real-time detection and characterization of regulated and small-molecule-induced protein-protein interactions in intact cells and living animals and enables a wide range of novel applications in drug discovery, chemical genetics, and proteomics research.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17461729     DOI: 10.1146/annurev.bioeng.9.060906.152044

Source DB:  PubMed          Journal:  Annu Rev Biomed Eng        ISSN: 1523-9829            Impact factor:   9.590


  42 in total

Review 1.  On in vivo imaging in cancer.

Authors:  David Piwnica-Worms
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-03-01       Impact factor: 10.005

2.  Design and Synthesis of an Alkynyl Luciferin Analogue for Bioluminescence Imaging.

Authors:  Rachel C Steinhardt; Jessica M O'Neill; Colin M Rathbun; David C McCutcheon; Miranda A Paley; Jennifer A Prescher
Journal:  Chemistry       Date:  2016-01-19       Impact factor: 5.236

Review 3.  Advances in bioluminescence imaging of live animal models.

Authors:  Robin S Dothager; Kelly Flentie; Britney Moss; Mei-Hsiu Pan; Aparna Kesarwala; David Piwnica-Worms
Journal:  Curr Opin Biotechnol       Date:  2009-02-23       Impact factor: 9.740

Review 4.  Bimolecular fluorescence complementation: lighting up seven transmembrane domain receptor signalling networks.

Authors:  Rachel H Rose; Stephen J Briddon; Nicholas D Holliday
Journal:  Br J Pharmacol       Date:  2009-12-10       Impact factor: 8.739

5.  Imaging of molecular signatures of specific structures, functions,and pathological alterations in the lung tissue.Chair's Summary.

Authors:  Vladimir R Muzykantov
Journal:  Proc Am Thorac Soc       Date:  2009-08-15

6.  Enhanced red-emitting railroad worm luciferase for bioassays and bioimaging.

Authors:  Xueyan Li; Yoshihiro Nakajima; Kazuki Niwa; Vadim R Viviani; Yoshihiro Ohmiya
Journal:  Protein Sci       Date:  2010-01       Impact factor: 6.725

7.  Luciferase fragment complementation imaging of conformational changes in the epidermal growth factor receptor.

Authors:  Katherine S Yang; Ma Xenia G Ilagan; David Piwnica-Worms; Linda J Pike
Journal:  J Biol Chem       Date:  2009-01-26       Impact factor: 5.157

Review 8.  Comparative analysis of the liver and plasma proteomes as a novel and powerful strategy for hepatocellular carcinoma biomarker discovery.

Authors:  Laura Beretta
Journal:  Cancer Lett       Date:  2009-02-15       Impact factor: 8.679

9.  Protein-Protein Interactions as New Targets for Ion Channel Drug Discovery.

Authors:  Svetla Stoilova-McPhie; Syed Ali; Fernanda Laezza
Journal:  Austin J Pharmacol Ther       Date:  2013-12-31

Review 10.  Illuminating cancer systems with genetically engineered mouse models and coupled luciferase reporters in vivo.

Authors:  Brandon Kocher; David Piwnica-Worms
Journal:  Cancer Discov       Date:  2013-04-12       Impact factor: 39.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.